Investor

Oncology Venture US was spun out from Oncology Venture ApS in the third quarter of 2016, and completed a $3.5 million Seed financing in the fourth quarter of 2016. Formerly known as 2X Oncology, we rebranded in June 2018 to reflect that its product candidates and the DRP technology aim to benefit cancer patients of all genders.

Our current investor presentation is linked here.

For further information, or to schedule a meeting with the OV-US team, please contact Amy Raskopf (amy.raskopf@2Xoncology.com).